Introduction Perampanel is an AMPA receptor antagonist recently approved for the treatment
of partial and generalized epilepsies with tonic–clonic seizures as an add-on therapy …

Introduction Perampanel is an AMPA receptor antagonist recently approved for the treatment
of partial and generalized epilepsies with tonic-clonic seizures as an add-on therapy …

Introduction Perampanel is an AMPA receptor antagonist recently approved for the treatment
of partial and generalized epilepsies with tonic–clonic seizures as an add-on therapy …

Methods This single-center postmarketing study retrospectively evaluated the efficacy of
perampanel in patients with partial onset and other seizure types, with a special emphasis …

Perampanel is an AMPA receptor antagonist recently approved for the treatment of partial
and generalized epilepsies with tonic–clonic seizures as an add-on therapy. This single …